Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis.
Saved in:
| Title: | Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis. |
|---|---|
| Authors: | Moradi N; Core, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia., Sharmin S; Core, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Malpas CB; Core, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Melbourne School of Psychological Sciences, the University of Melbourne, Australia., Kuhle J; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University of Basel, Basel, Switzerland., Benkert P; Clinical Trial Unit, Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland., Leppert D; Neurologic Clinic and Policlinic, MS Centre and Research Centre for Clinical Neuroimmunology and Neuroscience Basel, University of Basel, Basel, Switzerland., Havrdová EK; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Horáková D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Kleinová P; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Uher T; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Manouchehrinia A; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Hillert J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Olsson T; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Kochum I; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Taylor BV; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Barnett M; Brain and Mind Centre, the University of Sydney, Sydney, New South Wales, Australia.; Sydney Neuroimaging Analysis Centre, Camperdown, New South Wales, Australia., Kilpatrick TJ; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia., Buzzard K; Department of Neurology, Box Hill Hospital, Melbourne, Australia., Kalincik T; Core, Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia. |
| Source: | European journal of neurology [Eur J Neurol] 2026 Feb; Vol. 33 (2), pp. e70505. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
